Variation in camptothecin content in Camptotheca acuminata leaves

Botanical Bulletin of Academia Sinica

Volumn 44, Issue 2, 2003, Pages 99-105

  Yan, Xiu Feng ^a   Wang, Yang ^a   Yu, Tao ^a   Zhang, Yu Hong ^a   Dai, Shao Jun ^a,b  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

^b HARBIN NORMAL UNIVERSITY   (China)

Author keywords

Camptotheca acuminata leaves; Camptothecin; CPT optimization

Indexed keywords

CAMPTOTHECA ACUMINATA;

EID: 0038356594     PISSN: 00068063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Abigerges, D., G.G. Chabot, J.P. Armand, P. Herait, A. Gouyette, and D. Gandia. 1995. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. J. Clin. Oncol. 13: 210-221.
2. Bleiberg, H. 1999. CPT-11 in gastrointestinal cancer. Eur. J. Cancer 35: 371-379.
3. Burke, T.G. 1996. Chemistry of the camptothecins in the bloodstream: drug stabilization and optimization of activity. In P. Pantazis, B.C. Giovanella, and M.L. Rothenberg (eds.), The Camptothecins from Discovery to the Patient, The New York Academy of Sciences, New York, pp. 29-31.
4. Cao, G.R., J.X. Gao, D.X. Duan, S.J. Li, and K. Wang. 1986. Studies on Camptotheca acuminata leaves: main toxic principle, poisoning, and treatment in goats. In L.F. James, R.F. Keeler, E.M. Bailey, Jr., P.R. Cheeke and M.P. Hegarty (eds.), Proc. Third Int. Symp., pp. 506-508.
5. Clements, M.K., C.B. Jones, M. Cumming, and S.S. Daoud. 1999. Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother. Pharmacol. 44: 411-416.
6. Giovanella, B.C. 1997. Topoismerase I Inhibitors. In B.A. Teicher (ed.), Cancer Therapeutics: Experimental and Clinical Agents, Humana Press, Totowa, pp. 137-152.
7. Jeha, S., H. Kantarjian, S. O'Brien, L. Vitek, and M. Beran. 1998. Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia. Leuk Lymphoma. 32: 159-164.
8. Lilenbaum, R.C., M.J. Ratain, A.A. Miller, J.B. Hargis, D.R. Hollis, G.L. Rosner, S.M. O'Brien, L. Brewster, M.R. Green, and R.L. Schilsky. 1995. Phase I study of paclitaxel and topotecan in patients with advanced tumors: A cancer and leukemia group B study. J. Clin. Oncol. 13: 2230-2237.
9. Lin, L., Z. Zhao, and R. Xu. 1977. Study on chemical components in Camptotheca acuminata, an anti-cancer plant I Chemical components in roots of C. acuminata. Acta Chim. Sin. 35: 227-230.
10. Li, S.Y. and K.T. Adair. 1994. Camptotheca acuminata Decaisne XI SHU (Chinese Happytree) a promising anti-tumor and anti-viral tree for the 21st century. Texas: The Tucker Center College of Forestry Stephen F. Austin state University Nacogdoches.
11. Liu, Z., S.B. Carpenter, and R.J. Constantin. 1997. Camptothecin production in Camptotheca acuminata seedlings in response to shading and flooding. Can. J. Bot. 75: 368-373.
12. Lopez-Meyer, M. and C.L. Nessler. 1997. Tryptophan decarboxylase is encoded by two antonomously regulated genes in Camptotheca acuminata which are differentially expressed during development and stress. Plant J. 11: 1167-1175.
13. Lopez-Meyer, M., C.L. Nessler, and T.D. Mcknight. 1994. Sites of accumulation of the antitumor alkaloid camptothecin in Camptotheca acuminata. Planta Medica. 60: 558-560.
14. Masuda, N., M. Fukuoka, Y. Kusunoki, K. Matsui, N. Takifuji, S. Kudoh, S. Negoro, M. Nishioka, K. Nakagawa, and M. Takada. 1992. CPT-11 a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J. Clin. Oncol. 10: 1225-1229.
15. Romanelli, S., P. Perego, G. Pratesi, N. Carenini, M. Tortoreto, and F. Zunino. 1998. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems. Cancer Chemother. Pharmacol. 41: 385-390.
16. Stevenson, J.P., D. DeMaria, J. Sludden, S.B. Kaye, L. Paz-Ares, L.B. Grochow, A. McDonald, K. Selinger, P. Wissel, P.J. O'Dwyer, and C. Twelves. 1999. Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. Ann. Oncol. 10(3): 339-344.
17. Turner, I.M. 1995. Forliar defenses and habitat adversity of three woody plant communities in Singapore. Funct. Ecol. 9: 279-284.
18. Wall, M.E. and M.C. Wani. 1996. Camptothecin: discovery to clinic. In P. Pantazis, B. C. Giovanella, and M. L. Rothenberg (eds.), The Camptothecins from Discovery to the Patient. The New York Academy of Scienssces, New York, pp. 1-12.
19. Wall, M.E., M.C. Wani, C.E. Cook, and K.H. Palmer. 1966. Plant Antitumor Agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Amer. Chem. Soc. 88: 3888-3890.
20. Xia, J.J. 2000. Which drug could detoxify bees poisoned by Camptotheca acuminata. J. Bee, 11: 29.
21. Yan, X.F., Y. Wang, T. Yu, Y.H. Zhang, and L.J. Yin. 2002. Determination of camptothecin in the leaves of Camptotheca acuminata by HPLC. J. Instru. Anal. 21: 15-18.
22. Zhang, L.Y. and Y.Q. Yang. 1997. Determination of camptothecin in the Fruit of Camptotheca acuminata Decne. By RP HPLC. China J. Chin Materia Medica. 22(4): 234-235, 255.